Identification of several human urinary metabolites of 6-benzoyl benzoxazolinone by gas chromatography/mass spectrometry. 1991

M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
Groupe de recherches en biodynamique du médicament, Faculté de pharmacie de Clermont-Ferrand, France.

The biotransformation of 6-benzoyl benzoxazolinone (6-BB), a non-narcotic peripheral analgesic, was studied in eight healthy volunteers after oral administration of a single dose of 1 g. Urinary metabolites were extracted either with ethyl acetate at different pH values or by percolating at pH 5 through Amberlite XAD 2 ion-exchange resin. Eluates were concentrated under vacuum, purified by thin-layer chromatography and analysed by gas chromatography/mass spectrometry or direct insertion probe mass spectrometry. Metabolites were identified with reference to the mass spectra of various synthesized compounds assumed to be metabolites of 6-BB, as N-methylated or monohydroxylated compounds. Another metabolic pathway was cleavage of the benzoxazolinone heterocycle giving 2-amino-5-benzoyl phenol after hydrolysis and decarboxylation. N-methyl, N-acetyl and hydroxylated metabolites having an amino-5-benzoyl phenol structure were also found.

UI MeSH Term Description Entries
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D001583 Benzoxazoles Benzoxazole
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D023303 Oxazolidinones Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents. 1,3-Oxazolidin-2-one,Oxazolidin-2-one,Oxazolidinone,1,3-Oxazolidine-2-one,2-Oxazolidone,2-oxazolidinone,1,3 Oxazolidin 2 one,1,3 Oxazolidine 2 one,2 Oxazolidone,2 oxazolidinone,Oxazolidin 2 one

Related Publications

M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
March 1992, Journal of chromatography,
M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
January 2007, Rapid communications in mass spectrometry : RCM,
M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
April 1981, Anesthesiology,
M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
March 1994, Pharmacology & toxicology,
M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
March 2008, Journal of mass spectrometry : JMS,
M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
August 1991, Biological mass spectrometry,
M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
August 2000, Archives of pharmacal research,
M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
August 1979, Life sciences,
M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
February 1989, Biomedical & environmental mass spectrometry,
M Bastide, and J L Chabard, and C Lartigue, and H Bargnoux, and J Petit, and J A Berger, and H A Mansour, and D Lesieur, and N Buch
August 1990, Journal of steroid biochemistry,
Copied contents to your clipboard!